Matrix-based Approach to Potency Assay Development for Adoptive T Cell Therapies
Time: 12:00 pm
day: Conference Day One - Track A - AM
Details:
• Developing phase-appropriate T cell potency assays, balancing critical quality attributes and available technologies
• Leveraging compliant characterization technologies to gain a well-rounded understanding of T cell functionality
• Establishing a potency assay matrix, maximizing correlation to clinical efficacy while minimizing late-phase risk
